Mylan Ex-CEO and Glass Lewis Debate Proxy Adviser Power

A top proxy adviser and the ex-CEO of a Fortune 500 pharmaceutical company once targeted by an billionaire activist on Wednesday clashed over the role two advisory firms play in boardroom battles pitting insurgent-backed dissident directors against incumbent executives. "We should all be playing by the same rules," Robert Coury, Mylan Inc.'s executive chairman, told the U.S. Chamber of Commerce ...
Login to comment.